Annual Accounts Receivable
$2.74 M
+$2.60 M+1817.48%
December 31, 2024
Summary
- As of March 12, 2025, KROS annual accounts receivable is $2.74 million, with the most recent change of +$2.60 million (+1817.48%) on December 31, 2024.
- During the last 3 years, KROS annual accounts receivable has fallen by -$15.26 million (-84.77%).
- KROS annual accounts receivable is now -84.77% below its all-time high of $18.00 million, reached on December 31, 2021.
Performance
KROS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$2.74 M
+$2.35 M+606.70%
December 31, 2024
Summary
- As of March 12, 2025, KROS quarterly accounts receivable is $2.74 million, with the most recent change of +$2.35 million (+606.70%) on December 31, 2024.
- Over the past year, KROS quarterly accounts receivable has stayed the same.
- KROS quarterly accounts receivable is now -84.77% below its all-time high of $18.00 million, reached on December 31, 2021.
Performance
KROS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
KROS Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1817.5% | 0.0% |
| 3 y3 years | -84.8% | -84.8% |
| 5 y5 years | - | - |
KROS Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -84.8% | -100.0% | -84.8% | -100.0% |
| 5 y | 5-year | -84.8% | -100.0% | -84.8% | -100.0% |
| alltime | all time | -84.8% | -100.0% | -84.8% | -100.0% |
Keros Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.74 M(+1817.5%) | $2.74 M(+606.7%) |
| Sep 2024 | - | $388.00 K(+9600.0%) |
| Jun 2024 | - | $4000.00(-98.2%) |
| Mar 2024 | - | $226.00 K(+58.0%) |
| Dec 2023 | $143.00 K(>+9900.0%) | $143.00 K(>+9900.0%) |
| Dec 2022 | $0.00 | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) |
| Dec 2021 | $18.00 M(>+9900.0%) | $18.00 M(>+9900.0%) |
| Jun 2021 | - | $100.00 K(>+9900.0%) |
| Dec 2020 | $0.00 | $0.00 |
FAQ
- What is Keros Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Keros Therapeutics?
- What is Keros Therapeutics annual accounts receivable year-on-year change?
- What is Keros Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Keros Therapeutics?
- What is Keros Therapeutics quarterly accounts receivable year-on-year change?
What is Keros Therapeutics annual accounts receivable?
The current annual accounts receivable of KROS is $2.74 M
What is the all time high annual accounts receivable for Keros Therapeutics?
Keros Therapeutics all-time high annual accounts receivable is $18.00 M
What is Keros Therapeutics annual accounts receivable year-on-year change?
Over the past year, KROS annual accounts receivable has changed by +$2.60 M (+1817.48%)
What is Keros Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of KROS is $2.74 M
What is the all time high quarterly accounts receivable for Keros Therapeutics?
Keros Therapeutics all-time high quarterly accounts receivable is $18.00 M
What is Keros Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, KROS quarterly accounts receivable has changed by $0.00 (0.00%)